Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme Arginate to reduce delayed graft function in kidney transplant
NCT03646344Phase 3Terminated
- Sponsor
- University of Edinburgh
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of heme arginate in delayed graft function (DGF), sponsored by University of Edinburgh. Primary endpoint: Delayed Graft Function at 1 week. Started Mar 2019; status: terminated.
02
Drugs
heme arginate
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT03646344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03646344.